When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Androgen deprivation therapy - Wikipedia

   en.wikipedia.org/wiki/Androgen_deprivation_therapy

   Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones , such as testosterone , to grow.

3. Management of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Management_of_prostate_cancer

   The risk of dying from prostate cancer or having acute bladder side effects may be similar to that of longer radiation treatment. [28] Others use a "triple modality" combination of external beam radiation therapy, brachytherapy, and hormonal therapy.

4. Side effects of bicalutamide - Wikipedia

   en.wikipedia.org/wiki/Side_effects_of_bicalutamide

   These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...

5. Doctors don't always explain sexual side effects of prostate ...

   www.aol.com/news/doctors-dont-always-explain...

   Lower urinary tract symptoms and prostatic hyperplasia - an enlarged prostate - cause difficulty with urination, urgency and leaking. Doctors don't always explain sexual side effects of prostate ...

6. Toremifene - Wikipedia

   en.wikipedia.org/wiki/Toremifene

   In 2007 the pharmaceutical company GTx, Inc was conducting two different phase 3 clinical trials; First, a pivotal Phase clinical trial for the treatment of serious side effects of androgen deprivation therapy (ADT) (especially vertebral/spine fractures and hot flashes, lipid profile, and gynecomastia) for advanced prostate cancer, and second ...

7. Darolutamide - Wikipedia

   en.wikipedia.org/wiki/Darolutamide

   Darolutamide, sold under the brand name Nubeqa, is an antiandrogen medication which is used in the treatment of non-metastatic castration-resistant prostate cancer in men. [8] [4] [5] [9] [10] It is specifically approved to treat non-metastatic castration-resistant prostate cancer (nmCRPC) in conjunction with surgical or medical castration. [4]